Literature DB >> 476869

Coronary vasoactivity of adenosine in the conscious dog.

R A Olsson, E M Khouri, J L Bedynek, J McLean.   

Abstract

Intracoronary adenosine infusions in conscious dogs produced half-maximal coronary vasodilation at 0.57 +/- 0.18 (SD) microns and at 1.01 +/- 0.25 microns in open-chest dogs. In both preparations, adenosine at concentrations in the range found in cardiac muscle by direct analysis produced coronary vasodilation equal to that attained during a maximum reactive hyperemic response. The quantitative structure-activity relationship technique was applied to data on the coronary vasoactivity of 68 adenosine analogs to identify the chemical features of this molecule that determine its vasoactivity. These are: (1) the size of the purine base; (2) the inductive effect of C-2 substituent; (3) the electron-withdrawing effect of the C-6 substituent; (4) the glycosylic torsion angle; (5) the ability of the C-2' and C-3' hydroxyls to participate in hydrogen bonding; (7) the absence of sterically hindering groups in the vicinity of C-2' and, more importantly, C-3'; and (8) the inductive effect of the C-5' substituent. The hydrophobicity of these analogs did not correlate with vasoactivity, suggesting that the hydrophilicity of the ribose moiety overshadows any hydrophobic influence of the very weakly aromatic purine base.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 476869     DOI: 10.1161/01.res.45.4.468

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  11 in total

Review 1.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

2.  N6-functionalized congeners of adenosine with high potency at A2-adenosine receptors: potential ligands for affinity chromatography.

Authors:  K A Jacobson; N Yamada; K L Kirk; J W Daly; R A Olsson
Journal:  Biochem Biophys Res Commun       Date:  1986-05-14       Impact factor: 3.575

3.  Cardiac endothelial transport and metabolism of adenosine and inosine.

Authors:  L M Schwartz; T R Bukowski; J H Revkin; J B Bassingthwaighte
Journal:  Am J Physiol       Date:  1999-09

4.  EFA (9-beta-D-erythrofuranosyladenine) is an effective salvage agent for methylthioadenosine phosphorylase-selective therapy of T-cell acute lymphoblastic leukemia with L-alanosine.

Authors:  Ayse Batova; Howard Cottam; John Yu; Mitchell B Diccianni; Carlos J Carrera; Alice L Yu
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

5.  Feasibility and safety of high-dose adenosine perfusion cardiovascular magnetic resonance.

Authors:  Theodoros D Karamitsos; Ntobeko A B Ntusi; Jane M Francis; Cameron J Holloway; Saul G Myerson; Stefan Neubauer
Journal:  J Cardiovasc Magn Reson       Date:  2010-11-16       Impact factor: 5.364

6.  The release of adenosine and inosine from canine subcutaneous adipose tissue by nerve stimulation and noradrenaline.

Authors:  B B Fredholm; A Sollevi
Journal:  J Physiol       Date:  1981       Impact factor: 5.182

7.  Endothelial cell uptake of adenosine in canine skeletal muscle.

Authors:  M W Gorman; J B Bassingthwaighte; R A Olsson; H V Sparks
Journal:  Am J Physiol       Date:  1986-03

8.  Coronary vasoactivity of acetate in dog and guinea-pig.

Authors:  N Yamada; R Bünger; C R Steinhart; R A Olsson
Journal:  Basic Res Cardiol       Date:  1986 Jul-Aug       Impact factor: 17.165

9.  Adenosine causes transient dilatation of coronary arteries in man.

Authors:  A H Watt; W J Penny; H Singh; P A Routledge; A H Henderson
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

10.  Assessment of Myocardial Perfusion at Rest and During Stress Using Dynamic First-Pass Contrast-Enhanced Magnetic Resonance Imaging in Healthy Dogs.

Authors:  Henning Richter; Patrick R Kircher; Fabiola B Joerger; Erika Bruellmann; Matthias Dennler
Journal:  Front Vet Sci       Date:  2018-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.